TerrAscend (TRSSF) & Its Competitors Critical Contrast

TerrAscend (OTCMKTS:TRSSFGet Rating) is one of 32 publicly-traded companies in the “Agricultural production – crops” industry, but how does it weigh in compared to its peers? We will compare TerrAscend to related businesses based on the strength of its dividends, institutional ownership, earnings, risk, analyst recommendations, profitability and valuation.

Profitability

This table compares TerrAscend and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
TerrAscend -143.67% -8.24% -3.88%
TerrAscend Competitors -199.08% -18.48% -11.40%

Earnings & Valuation

This table compares TerrAscend and its peers gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
TerrAscend $210.42 million $3.11 million -1.33
TerrAscend Competitors $1.63 billion $92.12 million 7.26

TerrAscend’s peers have higher revenue and earnings than TerrAscend. TerrAscend is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Institutional & Insider Ownership

0.0% of TerrAscend shares are owned by institutional investors. Comparatively, 28.7% of shares of all “Agricultural production – crops” companies are owned by institutional investors. 44.3% of TerrAscend shares are owned by insiders. Comparatively, 21.5% of shares of all “Agricultural production – crops” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of current recommendations and price targets for TerrAscend and its peers, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TerrAscend 0 3 5 0 2.63
TerrAscend Competitors 56 137 440 23 2.66

TerrAscend currently has a consensus price target of $3.57, suggesting a potential upside of 100.37%. As a group, “Agricultural production – crops” companies have a potential upside of 63.97%. Given TerrAscend’s higher possible upside, equities research analysts plainly believe TerrAscend is more favorable than its peers.

Summary

TerrAscend peers beat TerrAscend on 7 of the 12 factors compared.

About TerrAscend

(Get Rating)

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. It produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis infused artisan edibles. The company also operates three retail dispensaries under the Apothecarium brand name in California and Pennsylvania. In addition, it owns various synergistic under Gage Cannabis, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc. brands. As of July 26, 2022, the company operated 27 dispensaries, including 3 Cookies dispensaries in Michigan and 1 in Toronto. TerrAscend Corp. was incorporated in 2017 and is headquartered in Mississauga, Canada.

Receive News & Ratings for TerrAscend Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TerrAscend and related companies with MarketBeat.com's FREE daily email newsletter.